Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the world and one of the leading indications for liver transplantation. It is one of the many …

Insulin-sensitizing medications were originally used in psychiatric practice to treat weight
gain and other metabolic side effects that accompany the use of mood stabilizers …

Background Patients with severe mental illness (SMI)(ie, schizophrenia, bipolar disorder, or
major depressive disorder) have been reported to have excess mortality rates from infection …

Background The most common causes of death in schizophrenia are cardiovascular
disorders, which are closely related to metabolic syndrome/obesity. To better understand the …

Compared to the general population, people with severe mental illness (SMI) have an
increased risk of weight gain and metabolic syndrome, but also of malnutrition, in part due to …

Objective While lifestyle medicine can be highly effective for treating a range of mental
illnesses these approaches are grossly underutilised and have not been systematically …

Background Type 2 diabetes is 2 to 3 times more common among people with severe
mental illness (SMI). Self-management is crucial, with additional challenges faced by people …

Background Obesity increases the chance of developing insulin resistance. Numerous
inflammatory markers have been linked to an increased risk of insulin resistance in obese …

Aims Epidemiological studies demonstrate an association between classes of obesity and
psychiatric disorders, although little is known about shared genetics and causality of …

Background: Obesity is highly prevalent and disabling, especially in individuals with severe
mental illness including bipolar disorders (BD). The brain is a target organ for both obesity …